feed,title,long_url,short_url
Benzinga,Takeda's Maribavir Hits Primary Endpoint Goal In Late-Stage Study In Transplant Recipients,https://www.benzinga.com/general/biotech/21/02/19633614/takedas-maribavir-hits-primary-endpoint-goal-in-late-stage-study-in-transplant-recipients,https://j.mp/3d5ZRbv
